Becker's Healthcare November 8, 2023
Medical device manufacturer Zimmer Biomet is keeping a close eye on the “rapid” shift of orthopedic and joint replacement cases to the ASC setting.
The company plans to be “relentless” about its ASC opportunities in the U.S. moving forward, according to a transcript from the company’s Nov. 7 third quarter earnings call.
In the third quarter, the company had a strong showing in the ASC setting, with facilities increasingly adopting its Rosa joint replacement robot.
Zimmer Biomet is also benefiting from the recent acquisitions it has made in the ASC space, including the additions of Embody, a devicemaker that focuses on soft tissue healing, and ReLign, which developed a three-in-one arthroscopy system.
“The ASC is one...
Today's Sponsors
Today's Sponsor